Cleared Traditional

K010473 - SPARROWHAWK DISPOSABLE

K010473 is an FDA 510(k) clearance for SPARROWHAWK DISPOSABLE, manufactured by Atc Technologies, Inc.. The device is a Class 2 Cardiovascular device with product code DWZ cleared through the Traditional 510(k) pathway after a 106-day FDA review.

K010473 · Atc Technologies, Inc. · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jun 2001
Decision
106d
Days
Class 2
Risk

K010473 is an FDA 510(k) clearance for the SPARROWHAWK DISPOSABLE. Classified as Device, Biopsy, Endomyocardial (product code DWZ), Class II - Special Controls.

Submitted by Atc Technologies, Inc. (Woburn, US). The FDA issued a Cleared decision on June 6, 2001 after a review of 106 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.4075 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K010473

510(k) Number K010473 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 20, 2001
Decision Date June 06, 2001
Days to Decision 106 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
19d faster than avg
Panel avg: 125d · This submission: 106d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DWZ Device Classification - Class 2, Special Controls

Product Code DWZ Device, Biopsy, Endomyocardial
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.4075
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DWZ Device, Biopsy, Endomyocardial

All 18
Devices cleared under the same product code (DWZ) and FDA review panel - the closest regulatory comparables to K010473.
Biopsy Forceps
K252722 · Fehling Instruments GmbH · Sep 2025
Biopsy Forceps
K170726 · Fehling Instruments GmbH & Co. KG · Jun 2017
NOVATOME, MODEL: SU101-50
K072051 · Scholten Surgical Instruments, Inc. · Oct 2007
MODIFICATION TO T-REX BIOPSY FORCEPS
K000409 · Boston Scientific Corp · Feb 2000
ULTRA-CBX
K991486 · Medcanica, Inc. · Nov 1999
T-REX BIOPSY FORCEPS
K973818 · Boston Scientific Corp · Dec 1997